Total Bilirubin
Diazo Colorimetry, Bilirubin. 510(k) K060574, from Abbott Laboratories (Irving, TX). Product code CIG, class 2.
As of Nov 20, 2026, K060574 is an FDA 510(k) held by Abbott Laboratories, substantially equivalent on May 3, 2006 after 58 days, with no recalls tied to it in FDA's recall database.
- Review time: 58 days
- Recalls: 0
- Cited as a predicate by: 1 device
The Total Bilirubin assay is used for the quantitation of total bilirubin in human serum or plasma. Measurement of total bilirubin, an organic compound formed during the normal and abnormal destruction of red blood cells, is used in the diagnosis and treatment of liver, hemolytic hematological, and metabolic disorders, including hepatitis and gall bladder block.
- Roche Reagent for Total BilirubinK910591 · Roche Diagnostic Systems, Inc. · Apr 24, 1991
- Architect Total BilirubinK121985 · Abbott Laboratories · Feb 1, 2013
- Atellica CH Diazo Total Bilirubin (D_TBil)K251998 · Siemens Healthcare Diagnostics, Inc. · Feb 27, 2026
- Atellica® CH Diazo Direct Bilirubin (D_DBil)K223078 · Siemens Healthcare Diagnostics, Inc. · Jun 12, 2023
- Atellica® CH Diazo Total Bilirubin (D_TBil)K222104 · Siemens Healthcare Diagnostics, Inc. · Mar 20, 2023
- Total Bilirubin2K223324 · Abbott Ireland Diagnostics Division · Dec 29, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 6, 2006
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1110
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files